Drug Database
Back to search

Italy· 045255027

AFSTYLA*1 flaconcino EV polv 500 Unita' Internazionali + 1 flaconcino 2,5 ml

A blood coagulation factors product containing lonoctocog alfa, registered in Italy by CSL BEHRING GmbH, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC B02BD

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedAFSTYLA*1 flaconcino EV polv 500 Unit…ATCB02BDREGISTER NO.045255027PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lonoctocog alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lonoctocog alfa is registered in 4 of 19 countries.

Countries holding a registration under ATC B02BD (blood coagulation factors), each read from that country’s own register.

  • This record: Italy
  • 2 of them publish a price we can compare per daily dose
Search lonoctocog alfa products by name

Lonoctocog alfa · ATC B02BD

4 / 19 countries

  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Lonoctocog Alfa
Manufacturer
CSL BEHRING GmbH
Country
Italy (IT)
ATC code
B02BD
ATC class
Blood coagulation factors
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    045255027
    AFSTYLA*1 flaconcino EV polv 500 Unita' Internazionali + 1 flaconcino 2,5 ml
    EUR 610.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lonoctocog alfa in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lonoctocog alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Afstyla
  • Liechtenstein · Afstyla
  • Norway · Afstyla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/962609e3-e5e9-4204-b236-bcbe0b81657a
GET /v1/drugs/962609e3-e5e9-4204-b236-bcbe0b81657a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 610.65,
  "source": "aifa",
  "currency": "EUR",
  "strength": "LONOCTOCOG ALFA 500UI 2,5ML 1 UNITA' USO PARENTERALE",
  "substance": "Lonoctocog Alfa",
  "equivalence_group": "KBM",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about lonoctocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console